News
2025
-
Information
-
Sysmex’s Automated Blood Coagulation Analyzer CN™-6000 Receives U.S. FDA 510(k) Clearance
-
Press Release
-
Sysmex Completes Subsidiary's New Instrument Manufacturing Factory in Nagano, Japan, and Begins Product Shipments
- Strengthening the Group’s Instrument Production System to Ensure Stable Global Supply and Enhanced Productivity -
-
Press Release
-
Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2025 (PDF：357KB)
-
Press Release
-
Sysmex Announces Changes from Financial Forecasts and Year-End Dividend for the Fiscal Year Ended March 31, 2025 (PDF：130KB)
-
Press Release
-
Notification Regarding Reversal of Deferred Tax Assets (Non-Consolidated Financial Results) (PDF：97KB)
-
Press Release
-
Announcement of Executive Changes (PDF：205KB)
-
Press Release
-
Announcement Regarding the Introduction of the Performance-Linked Stock Compensation Plan (PDF：216KB)
-
Press Release
-
Sysmex and Gaudi Clinical Agree on a Business Collaboration and Capital Alliance
- Aiming to Provide Safer, Higher Quality Treatments in the Field of Regenerative Cellular Medicine -
-
Press Release
-
Sysmex Group’s New Manufacturing Base in India Begins Full-Scale Operations and Launches “Make in India” Products
-
Press Release
-
Sysmex Establishes a Subsidiary in Kenya
- Strengthening Business Foundations in East Africa -
-
Press Release
-
Sysmex to Relocate Sysmex Group Headquarters to a New Location in Kobe City in Spring 2028
-
Press Release
-
Sysmex Acquires Naming Rights for the New Kobe Bunka Hall
- Contributing to Further Development of Culture and Arts in Kobe -
-
Information
-
[Conference presentation] Presenting the AD/PD™ 2025 International Conference on Alzheimer’s and Parkinson’s Diseases
-
Information
-
Sysmex to be Special Sponsor of Kobe Marathon 2025 – Supporting the Event with the Aims of Achieving a Healthy, Prosperous Society and Vibrant Local Communities –
-
Press Release
-
Sysmex and J-TEC Sign a Research Collaboration Agreement Regarding Sterility Testing in Regenerative Medicine and Cell Therapy
-
Press Release
-
Sysmex Begins Sales of Diabetes Testing Panel Including HISCL™ C-Peptide Assay Kit in Japan
-
Information
-
Implementing the Group-wide Unified Social Contribution Activity, the “Sysmex Gives Back Campaign”
-
Group Company News
-
Medicaroid Files for CE Mark Certification Under MDR for the hinotori™ Surgical Robot System
-
Information
-
Educational Initiatives for the Next Generation
- Implementing Health Education for Elementary School Students and SDG Education for Junior and Senior High School Students -
-
Press Release
-
Announcement of Organizational and Personnel Changes (PDF：212KB)
-
Information
-
Sysmex Receives ”Human Capital Management Quality Gold Award 2024” for Excellent Human Capital Management and Information Disclosure
-
Information
-
Sysmex Ranked in the Top 1% in the Sustainability Yearbook 2025 by S&P Global
-
Press Release
-
Notice Regarding the Completion of an Investigation by the Japan Fair Trade Commission (PDF：101KB)
-
Press Release
-
Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2025 (PDF：317KB)
-
Press Release
-
Sysmex Announces First Case in Malaysia Performed with the hinotori™ Surgical Robot System
- Accelerating Market Introduction in the Asia-Pacific Region -
-
Information
-
Sysmex Selected as One of the Global 100's Most Sustainable Companies in the World for the Sixth Time
